Your session is about to expire
← Back to Search
Probiotic
Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
N/A
Waitlist Available
Research Sponsored by Integrative Skin Science and Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4,8,12 weeks
Summary
The purpose of this study is to determine how probiotics affect sebum production and gut health in those with acne vulgaris.
Eligible Conditions
- Acne Vulgaris
- Acne
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4,8,12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4,8,12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Blood acetate levels
Microbiota Diversity
Short chain fatty acids
Secondary study objectives
Change in sebum excretion rate
Change in skin hydration
Change in skin microbiome
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ProbioticExperimental Treatment1 Intervention
Participants will be taking a probiotic supplement that they will be taking by mouth once per day.
Group II: PlaceboPlacebo Group1 Intervention
Participants will be taking a placebo supplement that they will be taking by mouth once per day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Probiotic
2013
Completed Phase 4
~3570
Find a Location
Who is running the clinical trial?
Microbiome labsUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
Integrative Skin Science and ResearchLead Sponsor
32 Previous Clinical Trials
1,904 Total Patients Enrolled
5 Trials studying Acne Vulgaris
194 Patients Enrolled for Acne Vulgaris